| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 42.218 | 49.600 | 36.833 | 31.481 | 23.276 | 11.240 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 42.218 | 49.600 | 36.833 | 31.481 | 23.276 | 11.240 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 35.231 | 41.711 | 36.507 | 34.318 | 25.575 | 13.125 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 6.987 | 7.888 | 326 | -2.838 | -2.299 | -1.885 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 5.720 | 7.392 | 50 | -3.150 | -2.532 | -1.995 | 0 | 0 | 0 | 0 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Phyto Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21 | 0 | 1.130 | 577 | 87 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.246 | 13.870 | 13.473 | 8.038 | 6.387 | 466 | 49 | 49 | 49 | 48 |
| Inventories | 6.361 | 6.395 | 7.090 | 6.847 | 5.986 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 15 | 6.123 | 5.112 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 870 | 1.352 | 1.272 | 1.191 | 402 | 466 | 49 | 49 | 49 | 48 |
| Shareholders Funds | 996 | 8.378 | 8.286 | 4.136 | 1.524 | -499 | -488 | -490 | -488 | -485 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.271 | 5.492 | 6.318 | 4.479 | 4.950 | 965 | 537 | 539 | 537 | 534 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1083 - 1083" | |||||||||
| CAEN Financial Year |
1083
|
|||||||||
Comments - Phyto Pharm Srl